Pembroke Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$584K Sell
487
-1
-0.2% -$1.02K 0.09% 59
2026
Q1
$449K Buy
488
+28
+6% +$28.4K 0.06% 79
2025
Q4
$494K Buy
460
+116
+34% +$111K 0.05% 77
2025
Q3
$262K Buy
+344
New +$256K 0.03% 84

Other funds holding LLY

Pembroke Management's LLY Position: Q2 2026 in Review

Pembroke Management reduced its Eli Lilly (LLY) stake by 0.2% in Q2 2026, selling an estimated $1.02K and leaving 487 shares worth $584K. The position accounts for 0.09% of the portfolio, ranked #59.

Pembroke Management first reported a position in LLY in Q3 2025 and has held it in 4 quarters since. 1,405 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Pembroke Management held 487 shares of Eli Lilly worth $584K as of Q2 2026.
  • Pembroke Management sold 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
  • Eli Lilly made up 0.09% of Pembroke Management's portfolio in Q2 2026, its #59 holding.
  • Pembroke Management first reported a position in Eli Lilly in Q3 2025 and has held it in 4 quarters since.
  • 1,405 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Pembroke Management's 13F filing for Q2 2026, filed 22 Jul 2026.